BIO-key International, Inc. (NASDAQ:BKYI) Short Interest Up 40.7% in July

BIO-key International, Inc. (NASDAQ:BKYIGet Free Report) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totalling 20,400 shares, a growth of 40.7% from the June 30th total of 14,500 shares. Based on an average daily volume of 11,500 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.2% of the company’s stock are short sold.

BIO-key International Stock Performance

BKYI stock remained flat at $1.62 during trading hours on Friday. 9,556 shares of the company’s stock were exchanged, compared to its average volume of 10,320. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.68 and a quick ratio of 0.55. The company’s fifty day moving average is $1.70 and its 200-day moving average is $1.82. BIO-key International has a 12-month low of $1.25 and a 12-month high of $13.68.

BIO-key International (NASDAQ:BKYIGet Free Report) last announced its quarterly earnings results on Friday, June 14th. The technology company reported ($0.32) EPS for the quarter. The firm had revenue of $2.18 million during the quarter. BIO-key International had a negative net margin of 96.03% and a negative return on equity of 340.45%.

About BIO-key International

(Get Free Report)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Read More

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.